| Expression pattern: |
DN |
| Associated gene: |
EIF4A3, FUS, K-RAS, MEK, ERK1, Bcl2, BAD, caspase-3 |
| Associated microRNA: |
miR-125, miR-138, miR-149 |
| Biological function: |
Inhibits MCF-7 cell proliferation and colony formation, blocks the cell cycle at G1/S phase, and promotes apoptosis. |
| Molecular mechanism: |
circNR4A1 overexpression suppresses K-RAS/MEK/ERK and Bcl2 expression while increasing BAD and caspase-3 expression; predicted mechanisms include microRNA binding and RNA-binding protein binding. |
| Biological pathway or process: |
ERK (inhibits); apoptosis (promotes); proliferation (inhibits); cell cycle (inhibits); ceRNA regulation (other) |
| Detected method: |
Q
M
|
| Validation methods: |
Microarray; RT-qPCR; RNase R Treatment; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; Transfection; CCK8; Colony Formation Assay; Annexin V/PI Flow Cytometry; Cell Cycle Assay; Western Blot; Bioinformatics Analysis |
| Clinical significance: |
circNR4A1 has potential as a molecular diagnostic biomarker and a new molecular therapeutic target for breast cancer. |
| Description: |
circNR4A1/Hsa-circ-0026352 is down-regulated in breast cancer tissues, patient peripheral blood, and breast cancer cell lines. Its overexpression in MCF-7 cells suppresses proliferation and colony formation, arrests the cell cycle at G1/S, and promotes apoptosis, likely involving inhibition of the K-RAS/MEK/ERK pathway and modulation of apoptosis-related proteins. The study suggests circNR4A1 may serve as a diagnostic biomarker and potential therapeutic target in breast cancer. |
| Confidence score: |
0.697 |